N-[(3S)-1-(3-ethylpyrrolo[1,2-a]pyrazin-1-yl)pyrrolidin-3-yl]-2-(4-hydroxypiperidin-1-yl)-1,3-thiazole-4-carboxamide;1-(4-fluorophenyl)-N-[(3R)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]-1,2,4-triazole-3-carboxamide;6-(4-hydroxypiperidin-1-yl)-N-[(3S)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]pyridazine-3-carboxamide;2-(4-hydroxypiperidin-1-yl)-N-[(3S)-1-(3-propan-2-ylpyrrolo[1,2-a]pyrazin-1-yl)pyrrolidin-3-yl]-1,3-thiazole-4-carboxamide
C84H99FN28O7S2 — CID 159927467
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(3S)-1-(3-ethylpyrrolo[1,2-a]pyrazin-1-yl)pyrrolidin-3-yl]-2-(4-hydroxypiperidin-1-yl)-1,3-thiazole-4-carboxamide;1-(4-fluorophenyl)-N-[(3R)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]-1,2,4-triazole-3-carboxamide;6-(4-hydroxypiperidin-1-yl)-N-[(3S)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]pyridazine-3-carboxamide;2-(4-hydroxypiperidin-1-yl)-N-[(3S)-1-(3-propan-2-ylpyrrolo[1,2-a]pyrazin-1-yl)pyrrolidin-3-yl]-1,3-thiazole-4-carboxamide
N-[(3S)-1-(3-ethylpyrrolo[1,2-a]pyrazin-1-yl)pyrrolidin-3-yl]-2-(4-hydroxypiperidin-1-yl)-1,3-thiazole-4-carboxamide;1-(4-fluorophenyl)-N-[(3R)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]-1,2,4-triazole-3-carboxamide;6-(4-hydroxypiperidin-1-yl)-N-[(3S)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]pyridazine-3-carboxamide;2-(4-hydroxypiperidin-1-yl)-N-[(3S)-1-(3-propan-2-ylpyrrolo[1,2-a]pyrazin-1-yl)pyrrolidin-3-yl]-1,3-thiazole-4-carboxamide (PubChem CID 159927467) has the molecular formula C84H99FN28O7S2 and a molecular weight of 1696.04 g/mol. Its IUPAC name is N-[(3S)-1-(3-ethylpyrrolo[1,2-a]pyrazin-1-yl)pyrrolidin-3-yl]-2-(4-hydroxypiperidin-1-yl)-1,3-thiazole-4-carboxamide;1-(4-fluorophenyl)-N-[(3R)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]-1,2,4-triazole-3-carboxamide;6-(4-hydroxypiperidin-1-yl)-N-[(3S)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]pyridazine-3-carboxamide;2-(4-hydroxypiperidin-1-yl)-N-[(3S)-1-(3-propan-2-ylpyrrolo[1,2-a]pyrazin-1-yl)pyrrolidin-3-yl]-1,3-thiazole-4-carboxamide.
Molecular Properties
| Compound Name | N-[(3S)-1-(3-ethylpyrrolo[1,2-a]pyrazin-1-yl)pyrrolidin-3-yl]-2-(4-hydroxypiperidin-1-yl)-1,3-thiazole-4-carboxamide;1-(4-fluorophenyl)-N-[(3R)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]-1,2,4-triazole-3-carboxamide;6-(4-hydroxypiperidin-1-yl)-N-[(3S)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]pyridazine-3-carboxamide;2-(4-hydroxypiperidin-1-yl)-N-[(3S)-1-(3-propan-2-ylpyrrolo[1,2-a]pyrazin-1-yl)pyrrolidin-3-yl]-1,3-thiazole-4-carboxamide |
|---|---|
| PubChem CID | 159927467 |
| Molecular Formula | C84H99FN28O7S2 |
| Molecular Weight | 1696.04 g/mol |
| Exact Mass | 1694.77 |
| IUPAC Name | N-[(3S)-1-(3-ethylpyrrolo[1,2-a]pyrazin-1-yl)pyrrolidin-3-yl]-2-(4-hydroxypiperidin-1-yl)-1,3-thiazole-4-carboxamide;1-(4-fluorophenyl)-N-[(3R)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]-1,2,4-triazole-3-carboxamide;6-(4-hydroxypiperidin-1-yl)-N-[(3S)-1-imidazo[1,2-a]pyrazin-8-ylpyrrolidin-3-yl]pyridazine-3-carboxamide;2-(4-hydroxypiperidin-1-yl)-N-[(3S)-1-(3-propan-2-ylpyrrolo[1,2-a]pyrazin-1-yl)pyrrolidin-3-yl]-1,3-thiazole-4-carboxamide |
| SMILES | CC(C)c1cn2cccc2c(N2CC[C@H](NC(=O)c3csc(N4CCC(O)CC4)n3)C2)n1.CCc1cn2cccc2c(N2CC[C@H](NC(=O)c3csc(N4CCC(O)CC4)n3)C2)n1.O=C(N[C@@H]1CCN(c2nccn3ccnc23)C1)c1ncn(-c2ccc(F)cc2)n1.O=C(N[C@H]1CCN(c2nccn3ccnc23)C1)c1ccc(N2CCC(O)CC2)nn1 |
| InChI | InChI=1S/C23H30N6O2S.C22H28N6O2S.C20H24N8O2.C19H17FN8O/c1-15(2)18-13-28-8-3-4-20(28)21(25-18)29-9-5-16(12-29)24-22(31)19-14-32-23(26-19)27-10-6-17(30)7-11-27;1-2-15-12-27-8-3-4-19(27)20(23-15)28-9-5-16(13-28)24-21(30)18-14-31-22(25-18)26-10-6-17(29)7-11-26;29-15-4-9-26(10-5-15)17-2-1-16(24-25-17)20(30)23-14-3-8-28(13-14)19-18-21-6-11-27(18)12-7-22-19;20-13-1-3-15(4-2-13)28-12-23-16(25-28)19(29)24-14-5-8-27(11-14)18-17-21-6-9-26(17)10-7-22-18/h3-4,8,13-17,30H,5-7,9-12H2,1-2H3,(H,24,31);3-4,8,12,14,16-17,29H,2,5-7,9-11,13H2,1H3,(H,24,30);1-2,6-7,11-12,14-15,29H,3-5,8-10,13H2,(H,23,30);1-4,6-7,9-10,12,14H,5,8,11H2,(H,24,29)/t2*16-;2*14-/m0001/s1 |
| InChIKey | NZFALCWPCWMMHW-MWSBBPTBSA-N |
| XLogP | 7.15 |
| TPSA | 377.02 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 122 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1696.04 |
| LogP ≤ 5 | 7.15 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 33 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159927467 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.